688710 Shanghai InnoStar Bio-tech
- 38.45
- +0.41+1.08%
Shanghai InnoStar Bio-tech News
Verification opinion of Haitong Securities Co., Ltd. on Shanghai Yinuo Biotechnology Co., Ltd. increasing the estimated amount of daily related transactions in 2024
Announcement of Resolutions of the 9th Meeting of the Third Board of Supervisors
Announcement on changes in the company\'s senior management
Announcement on increasing the estimated amount of daily related transactions in 2024
INNOX Investor Relations Activity Record Form (2024-002)
Innox: Announcement on holding the results briefing for the third quarter of 2024
Announcement on holding the results briefing for the third quarter of 2024
Verification opinions of Haitong Securities Co., Ltd. on the use of capital raised by Shanghai Yinuo Biotechnology Co., Ltd. to increase capital and provide loans to wholly-owned subsidiaries to implement fund-raising projects
Announcement of Resolutions of the Eighth Meeting of the Third Board of Supervisors
Innox: Opinions of Haitong Securities Co., Ltd. on the verification of the amount of capital raised by Shanghai Yinuo Biotechnology Co., Ltd. to adjust the amount of capital raised in the fund-raising investment project
Innox: Opinions of Haitong Securities Co., Ltd. on the verification of Shanghai Yinuo Biotechnology Co., Ltd.\'s use of raised funds to replace pre-invested capital in fund-raising projects and self-funded funds paid for issuance
Innox: Announcement of Resolutions of the 7th Meeting of the 3rd Board of Supervisors
Innox: Announcement on the Appointment of a Representative for Securities Affairs
Innox: Announcement on the use of some temporarily idle funds raised for cash management
Innox: Announcement on the intention to sign a “Financial Service Agreement” and related transactions with Sinopharm Group Finance Co., Ltd.
Innox: Audit Report of Lixin Certified Public Accountants (Special General Partnership) on Shanghai Innox Biotechnology Co., Ltd.\'s self-funded pre-investment in fund-raising projects and payment of issuance fees
Innox: Announcement on adjusting the amount of capital to be invested in fund-raising projects
Innox: Articles of Association (October 2024)
Innox: Risk management plan for developing financial services such as deposits and loans at Sinopharm Group Finance Co., Ltd.
Innox: Announcement on the use of raised funds to replace pre-invested capital in fund-raising projects and self-funded funds already paid for issuance
Analysis
Price Target
No Data
No Data